Skip to content
Home
About
Who we are
Our Team
Distill EDC
Benefits
Features
Pricing
Industry News
Latest
RWE
Clinical Trials
Oncology
SVM
Case Studies
Publications
Endorsements
Pricing
Contact
×
Home
About
Who we are
Our Team
Distill EDC
Benefits
Features
Pricing
Industry News
Latest
RWE
Clinical Trials
Oncology
SVM
Case Studies
Publications
Endorsements
Pricing
Contact
PUBLICATIONS
A treatment evaluator tool to monitor the real-world effectiveness of inhaled aztreonam lysine in cystic fibrosis
09 February 2022
READ MORE
Posts navigation
← Real world outcomes in platinum sensitive relapsed ovarian, fallopian tube, or peritoneal cancer treated in routine clinical practice in the United Kingdom prior to poly-ADP ribose polymerase inhibitors
Effects of Initiating or Switching to a Six-Monthly Triptorelin Formulation on Prostate Cancer Patient– Healthcare Interactions and Hospital Resource Use: a Real-World, Retrospective, Non-Interventional Study →
